Gall Emmanuel, Pezel Théo, Lattuca Benoît, Hamzi Kenza, Puymirat Etienne, Piliero Nicolas, Deney Antoine, Fauvel Charles, Aboyans Victor, Schurtz Guillaume, Bouleti Claire, Fabre Julien, El Ouahidi Amine, Thuaire Christophe, Millischer Damien, Noirclerc Nathalie, Delmas Clément, Roubille François, Dillinger Jean-Guillaume, Henry Patrick
Department of Cardiology, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris, University of Paris, Inserm U-942, 10, rue Ambroise-Paré, 75010 Paris, France.
Department of Cardiology, Nîmes University Hospital, Montpellier University, Nîmes, France.
Arch Cardiovasc Dis. 2024 Mar;117(3):195-203. doi: 10.1016/j.acvd.2023.12.009. Epub 2024 Feb 11.
Intensive cardiac care units (ICCU) were initially developed to monitor ventricular arrhythmias after myocardial infarction. In recent decades, ICCU have diversified their activities.
To determine the type of patients hospitalized in ICCU in France.
We analysed the characteristics of patients enrolled in the ADDICT-ICCU registry (NCT05063097), a prospective study of consecutive patients admitted to ICCU in 39 centres throughout France from 7th-22nd April 2021. In-hospital major adverse events (MAE) (death, resuscitated cardiac arrest and cardiogenic shock) were recorded.
Among 1499 patients (median age 65 [interquartile range 54-74] years, 69.6% male, 21.7% diabetes mellitus, 64.7% current or previous smokers), 34.9% had a history of coronary artery disease, 11.7% atrial fibrillation and 5.2% cardiomyopathy. The most frequent reason for admission to ICCU was acute coronary syndromes (ACS; 51.5%), acute heart failure (AHF; 14.1%) and unexplained chest pain (6.8%). An invasive procedure was performed in 36.2%. "Advanced" ICCU therapies were required for 19.9% of patients (intravenous diuretics 18.4%, non-invasive ventilation 6.1%, inotropic drugs 2.3%). No invasive procedures or advanced therapies were required in 44.1%. Cardiac computed tomography or magnetic resonance imaging was carried out in 12.3% of patients. The median length of ICCU hospitalization was 2.0 (interquartile range 1.0-4.0) days. The mean rate of MAE was 4.5%, and was highest in patients with AHF (10.4%).
ACS remains the main cause of admissions to ICCU, with most having a low rate of in-hospital MAE. Most patients experience a brief stay in ICCU before being discharged home. AHF is associated with highest death rate and with higher resource consumption.
强化心脏监护病房(ICCU)最初是为监测心肌梗死后的室性心律失常而设立的。近几十年来,ICCU的业务范围有所拓展。
确定法国ICCU收治患者的类型。
我们分析了ADDICT-ICCU注册研究(NCT05063097)中入组患者的特征,该研究是一项对2021年4月7日至22日期间法国39个中心连续收治入ICCU的患者进行的前瞻性研究。记录住院期间的主要不良事件(MAE)(死亡、心脏骤停复苏和心源性休克)。
在1499例患者中(中位年龄65岁[四分位间距54 - 74岁],男性占69.6%,糖尿病患者占21.7%,当前或既往吸烟者占64.7%),34.9%有冠状动脉疾病史,11.7%有房颤,5.2%有心肌病。入住ICCU最常见的原因是急性冠状动脉综合征(ACS;51.5%)、急性心力衰竭(AHF;14.1%)和不明原因胸痛(6.8%)。36.2%的患者接受了侵入性操作。19.9%的患者需要“高级”ICCU治疗(静脉利尿剂18.4%、无创通气6.1%、强心药物2.3%)。44.1%的患者无需侵入性操作或高级治疗。12.3%的患者进行了心脏计算机断层扫描或磁共振成像。ICCU住院中位时长为2.0天(四分位间距1.0 - 4.0天)。MAE的平均发生率为4.5%,在AHF患者中最高(10.4%)。
ACS仍然是入住ICCU的主要原因,大多数患者住院期间MAE发生率较低。大多数患者在出院回家前在ICCU停留时间较短。AHF与最高死亡率和更高的资源消耗相关。